Biosimilar Newsletter Archive

1. 10.17.19 -- Comparative Biosimilar Trials: More Questions Than Answers?
   10/17/2019
   10/17/19 Biosimilar Development Newsletter
2. 10.15.19 -- Scale-Up Strategies For Retroviruses, Mabs, And More
   10/15/2019
   10/15/19 Biosimilar Development Newsletter
3. 10.10.19 -- FDA's Woodcock: Biosimilar Development Promotes Better Biologics
   10/10/2019
   10/10/19 Biosimilar Development Newsletter
4. 10.08.19 -- Top Five Topics To Consider As You Advance Through Therapeutic Milestones
   10/8/2019
   10/08/19 Biosimilar Development Newsletter
5. 10.03.19 -- How This Initiative Improved Biosimilar Infliximab Uptake
   10/3/2019
   10/03/19 Biosimilar Development Newsletter
6. 09.26.19 -- Why This Biosimilar Initiative Is One To Watch
   9/26/2019
   09/26/19 Biosimilar Development Newsletter
7. 09.24.19 -- 5 Ways To Optimize Biomanufacturing Process Efficiency Now
   9/24/2019
   09/24/19 Biosimilar Development Newsletter
8. 09.19.19 -- What These 2 Policies Mean For Biosimilars
   9/19/2019
   09/19/19 Biosimilar Development Newsletter
9. 09.12.19 -- Is It Time To Change The Biosimilar Regulatory Paradigm?
   9/12/2019
   09/12/19 Biosimilar Development Newsletter
10. 09.10.19 -- Can Single-Use Film Be Optimized For The Entire Bioprocess Workflow?
    9/10/2019
    09/10/19 Biosimilar Development Newsletter